Reata Pharma (RETA) Prices 3.25M Class A Common Offering at $31/Sh
Tweet Send to a Friend
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) today announced the pricing of an underwritten public offering of 3,250,000 shares of its Class ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
